• April 30: The Week in Cancer News

    President Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.

    by Bradley Jones

  • Making Connections at the AACR Annual Meeting 2021

    Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience.

    by Bradley Jones

  • Building COVID-19 Vaccine Confidence

    Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.

    by Kevin McLaughlin

  • Chemobrain: It’s Not Your Imagination

    Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

    by Marci A. Landsmann

  • Forward Look

    Making Cancer Clinical Trials More Inclusive

    Despite efforts by policymakers, a gender gap persists in clinical trial participation.

    by Lindsey Konkel

  • Policy Matters

    Research Advocacy During COVID-19

    Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.

    by Brandon Leonard, MA, and Marc Johnson, MPP

  • Q&A

    Up for Debate

    Hematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.

    by Marci A. Landsmann

  • Get Involved

    Cakes for Cancer

    Inspired by a family friend, Chase Sloan has published a recipe book with proceeds going toward cancer research.

    by Erin O'Donnell

  • Survivor Profile

    A Return to Carnival

    With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.

    by Lindsey Konkel

  • A Drive for Diversity

    African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.

    by Jon Kelvey